Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.

By D. Blumberger, F. Vila-Rodriguez, K. Thorpe, K. Feffer, Y. Noda, P. Giacobbe, Yuliya Knyahnytska, Sidney H. Kennedy, R. Lam, Z. Daskalakis and 1 more. The Lancet, 2018

1,039 citations recorded by the source corpus.

Subfields: Anesthesiology and Pain Medicine, Neurology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/46593d43286be14d8bcd6da3e4cd164bd356ce66

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Psychiatry and Mental health

1. J. Keller
2. A. Schatzberg

Citations in the corpus

• Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018) (2019, neutral): “, 2015) and then in a controlled study but without comparison with a sham procedure (Blumberger et al., 2018).”
• Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial. (2021, methodology): “This is a departure from the more common single-time-point criterion for response or remission used in other iTBS clinical trials for depression (10).”
• Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines (2020, neutral): “, 2017a, b) that used TBS applied over the left frontal pole or the medial prefrontal at 110% of RMT and one study targeting the left DLPFC at 120% of RMT (Blumberger et al., 2018).”
• Theta-burst direct electrical stimulation remodels human brain networks (2024, unknown): “These analyses showed that functional, effective, and structural connectivity all contributed to an ability to predict the TBS-induce effects.”